Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunomodulatory effects of hydroxychloroquine on pregnancy outcomes in repeated implantation failure
IRCT20191231045960N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydroxychloroquine in female infertility and Recurrent Implantation Failure (RIF), sponsored by Mashhad University of Medical Sciences. Started Sep 2019; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
female infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20191231045960N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191231045960N1.